First Analysis Initiates Sharps Compliance With Overweight
Analysts at First Analysis initiated coverage on Sharps Compliance Corp. (NASDAQ: SMED) with a Overweight rating.
The target price for Sharps Compliance is set to $9.
Sharps Compliance shares have gained 49.34 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period.
Sharps Compliance shares climbed 0.90 percent to close at $6.75 yesterday.
Latest Ratings for SMED
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2020 | Stifel Nicolaus | Upgrades | Hold | Buy |
| Jul 2019 | Roth Capital | Initiates Coverage On | Buy | |
| Apr 2018 | Stifel Nicolaus | Downgrades | Buy | Hold |
View More Analyst Ratings for SMED
View the Latest Analyst Ratings
Posted-In: First AnalysisInitiation Analyst Ratings
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
